Karen, I have taken issue with you because this brilliant and philanthropic man whose inventions have helped diabetics, cardiac patients, patients with spinal cord injuries and lately the blind, has selflessly poured a billion dollars of his own money into Afrezza to help us, money he will never get back to once again help diabetics. And a lot of diabetics are bashing his invention. Have they tried it? No! And they should not try it if they are not interested. But they should ask questions from those who have used it and keep an open mind. Sanofi and probably all the pharma companies are in this business to MAKE MONEY, not give it away like Al Mann. And give it away he does. Selflessly. Your worry that if Afrezza takes off, injected insulin would be harder to get is groundless. As you know, all Type 1s need a basal insulin through injection or pump. Afrezza is a great bolus insulin and brings highs down within an hour. Other insulins cannot do this as they don't peak until an hour and a half and take from 3 to 5 hours to stop working. Which can be quite dangerous. Al Mann recognized this and invented Afrezza to help us. You don't have to try it. But when a large drug company who is in court defending itself against scuttling Lemtrada (I think?) a drug for multiple sclerosis, "partnering" with that company and losing them millions, not promoting it because they were supporting another drug due out in a year, they can be sued for their actions. And they are in court once again; Sanofi has been sued a lot. These drug companies know EXACTLY how much your disease profits them, yearly to the penny. And Sanofi has Apidra and a new injectable coming out now... They bought Afrezza to scuttle the competition. That's what Mannkind "owes" Sanofi. So when a drug, with the potential to help people the world over is sandbagged, skuttled, walked into bankruptcy, we need to care. Even if we don't use the drug. These are serious diseases and they are playing with lives here.